/ Credibility Index / Ro (Roman / Rory / Zero)

Ro (Roman / Rory / Zero)

DTC Telehealth · DTC telehealth — multi-vertical
C+

Mixed (C+) — Aesthetic Credibility Grade

Ro operates DTC telehealth across men's health (Roman), women's health (Rory), and weight loss (Zero). Mid-tier credentialing on aesthetic-adjacent services. The 2024 GLP-1 weight-loss product launch produced revenue growth but FDA scrutiny.

64
Composite / 100
/ Subscore Breakdown · 5 Dimensions

Where this grade comes from.

Practitioner Credentialing
C+
Injury / Complication Rate
C
Regulatory Track Record
C
Pricing Transparency
B-
Aftercare Quality
C
/ Public-Record Events

Key events & disclosures.

  • VC-backed
  • Zero GLP-1 weight-loss product launch 2023
  • FDA scrutiny of compounded GLP-1
  • 2022 $7B valuation; secondary trades at meaningful discount

/ Best for

Customers seeking convenient telehealth access to specific medications.

/ Watch out for

Compounded GLP-1 regulatory environment is uncertain. Limited in-person aesthetic services.